SYK · Stryker Corp
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-07-01 | Stryker to announce second quarter 2026 financial results |
| 2026-05-07 | Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio |
| 2026-05-07 | Stryker declares an $0.88 per share quarterly dividend |
| 2026-05-01 | Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference |
| 2026-04-30 |
Stryker reports first quarter 2026 operating results
Portage, Michigan, April 30, 2026 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the first quarter of 2026: First Quarter Results Reported net sales increased 2.6% to $6.0 billion Organic net sales increased 2.4% Reported operating income margin of 15.5% Adjusted operating income margin (1) contracted 180 bps to 21.1% Reported EPS increased 14.2% to $1.93 Adjusted EPS (1) decreased 8.5% to $2.60 First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic MedSurg and Neurotechnology 5.0 % 1.4 % 3.6 % |
| 2026-04-13 | Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio |
| 2026-04-01 | Stryker to announce financial results for its first quarter of fiscal year 2026 |
| 2026-03-31 | Stryker names Nick Mead Vice President, Investor Relations |
| 2026-03-23 | Stryker announces Annual Meeting of Shareholders |
| 2026-02-04 | Stryker declares an $0.88 per share quarterly dividend |
| 2026-01-29 |
Stryker reports 2025 operating results and 2026 outlook
Portage, Michigan, Jan. 29, 2026 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2025: Fourth Quarter Results Reported net sales increased 11.4% to $7.2 billion Organic net sales increased 11.0% Reported operating income margin of 25.2% Adjusted operating income margin (1) increased 100 bps to 30.2% Reported EPS increased 56.0% to $2.20 Adjusted EPS (1) increased 11.5% to $4.47 Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic MedSurg and Neurotechnology 17.5 % 0.9 % 16.6 % |
| 2026-01-05 |
Stryker to announce financial results for its fourth quarter and full year 2025
Portage, Michigan, Jan. 05, 2026 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will report financial results for its fourth quarter and full year 2025 on Thursday, January 29, 2026. A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s fourth quarter and full year that ended December 31, 2025. Stryker will host a webcast at 4:30 p.m. ET on Thursday, January 29, 2026, to discuss its fourth quarter and full year 2025 results. The webcast can be accessed at Stryker - Events & Presentations . An archive of the webcast will also be available on the company's website two hours after the live call ends. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help |